- Type / Class
- Equity / Common Stock
- Shares outstanding
- 76,424,795
- Total 13F shares
- 69,007,474
- Share change
- -3,604,868
- Total reported value
- $193,133,873
- Put/Call ratio
- 79%
- Price per share
- $2.80
- Number of holders
- 163
- Value change
- -$21,064,642
- Number of buys
- 73
- Number of sells
- 121
Quarterly Holders Quick Answers
What is CUSIP 690732102?
CUSIP 690732102 identifies ACH - ACCENDRA HEALTH INC/VA/ - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 690732102:
Top shareholders of ACH - ACCENDRA HEALTH INC/VA/ - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Coliseum Capital Management, LLC |
3/4/5
13D/G
13F
|
10%+ Owner · Company |
17%
from 13D/G
|
13,100,807
|
$69,565,285 | +$8,099,544 | 12 Aug 2025 | |
| BlackRock, Inc. |
13D/G
13F
|
Company |
7.1%
|
5,454,051
|
$29,888,199 | -$32,238,791 | 30 Sep 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
7.8%
|
5,962,847
|
$28,621,666 | — | 30 Sep 2025 | |
| FMR LLC |
13D/G
13F
|
Company |
3.5%
|
2,718,754
|
$18,895,342 | -$21,453,010 | 31 Mar 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13D/G
13F
|
Company |
4.5%
|
3,507,559
|
$16,836,283 | $0 | 30 Sep 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
4.3%
|
3,261,254
|
$15,654,019 | — | 30 Sep 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
4.2%
|
3,208,915
|
$15,402,792 | — | 30 Sep 2025 | |
| Invenomic Capital Management LP |
13F
|
Company |
3.6%
|
2,749,122
|
$13,195,786 | — | 30 Sep 2025 | |
| PARADIGM CAPITAL MANAGEMENT INC/NY |
13F
|
Company |
3.4%
|
2,611,600
|
$12,535,680 | — | 30 Sep 2025 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
3%
|
2,319,984
|
$11,135,923 | — | 30 Sep 2025 | |
| STATE STREET CORP |
13F
|
Company |
2.6%
|
1,964,536
|
$9,429,773 | — | 30 Sep 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
2.5%
|
1,893,777
|
$9,090,129 | — | 30 Sep 2025 | |
| MORGAN STANLEY |
13F
|
Company |
2.1%
|
1,601,058
|
$7,685,084 | — | 30 Sep 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.9%
|
1,460,801
|
$7,013,071 | — | 30 Sep 2025 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
1.7%
|
1,332,397
|
$6,395,506 | — | 30 Sep 2025 | |
| Dana Investment Advisors, Inc. |
13F
|
Company |
1.7%
|
1,265,560
|
$6,074,688 | — | 30 Sep 2025 | |
| TOWLE & CO |
13F
|
Company |
1.6%
|
1,247,959
|
$5,990,203 | — | 30 Sep 2025 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
1.4%
|
1,059,371
|
$5,084,981 | — | 30 Sep 2025 | |
| Nicholas J. Pace |
3/4/5
|
EVP, General Counsel |
—
class O/S missing
|
267,095
|
$4,829,078 | — | 15 May 2023 | |
| Connor, Clark & Lunn Investment Management Ltd. |
13F
|
Company |
1.2%
|
926,979
|
$4,449,499 | — | 30 Sep 2025 | |
| Christopher M. Lowery |
3/4/5
|
Former Pres, Global Products |
—
class O/S missing
|
232,120
|
$4,196,730 | — | 31 Mar 2022 | |
| Jochims Jeffrey T. |
3/4/5
|
EVP, COO and, President P&HS |
—
class O/S missing
|
195,956
|
$3,542,884 | — | 30 Jun 2022 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.94%
|
718,698
|
$3,449,751 | — | 30 Sep 2025 | |
| Empowered Funds, LLC |
13F
|
Company |
0.94%
|
716,184
|
$3,437,683 | — | 30 Sep 2025 | |
| HRT FINANCIAL LP |
13F
|
Company |
0.93%
|
711,684
|
$3,416,000 | — | 30 Sep 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.91%
|
696,791
|
$3,344,596 | — | 30 Sep 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.9%
|
690,800
|
$3,315,840 | — | 30 Sep 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.78%
|
598,663
|
$2,873,583 | — | 30 Sep 2025 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.78%
|
598,358
|
$2,872,118 | — | 30 Sep 2025 | |
| Shana Carol Neal |
3/4/5
|
Chief Human Resources Officer |
—
class O/S missing
|
158,594
|
$2,867,380 | — | 04 Mar 2022 | |
| UBS Group AG |
13F
|
Company |
0.78%
|
593,819
|
$2,850,331 | — | 30 Sep 2025 | |
| Trexquant Investment LP |
13F
|
Company |
0.77%
|
589,497
|
$2,829,586 | — | 30 Sep 2025 | |
| Y-Intercept (Hong Kong) Ltd |
13F
|
Company |
0.76%
|
582,747
|
$2,797,186 | — | 30 Sep 2025 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
0.71%
|
542,036
|
$2,601,773 | — | 30 Sep 2025 | |
| Mark F. Mcgettrick |
3/4/5
|
Director |
—
class O/S missing
|
121,644
|
$2,481,538 | — | 01 Jun 2022 | |
| Andrew G. Long |
3/4/5
|
EVP, CEO P&HS |
0.59%
|
448,425
|
$2,470,821 | — | 19 Nov 2025 | |
| LHM, INC. |
13F
|
Company |
0.65%
|
495,832
|
$2,379,994 | — | 30 Sep 2025 | |
| TUDOR INVESTMENT CORP ET AL |
13F
|
Company |
0.6%
|
461,252
|
$2,214,010 | — | 30 Sep 2025 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.59%
|
452,972
|
$2,174,266 | — | 30 Sep 2025 | |
| Walleye Capital LLC |
13F
|
Company |
0.54%
|
415,351
|
$1,993,685 | — | 30 Sep 2025 | |
| Daniel J. Starck |
3/4/5
|
EVP, Business Excellence |
—
class O/S missing
|
95,612
|
$1,891,205 | — | 15 May 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.47%
|
360,720
|
$1,731,455 | — | 30 Sep 2025 | |
| WOLVERINE ASSET MANAGEMENT LLC |
13F
|
Company |
0.42%
|
323,626
|
$1,553,404 | — | 30 Sep 2025 | |
| Jump Financial, LLC |
13F
|
Company |
0.4%
|
305,864
|
$1,468,147 | — | 30 Sep 2025 | |
| Mark P. Zacur |
3/4/5
|
EVP, Chief Commercial Officer |
—
class O/S missing
|
71,769
|
$1,297,584 | — | 03 Jun 2021 | |
| Nuveen, LLC |
13F
|
Company |
0.35%
|
263,916
|
$1,266,797 | — | 30 Sep 2025 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.34%
|
259,917
|
$1,247,602 | — | 30 Sep 2025 | |
| Mutual Advisors, LLC |
13F
|
Company |
0.3%
|
228,376
|
$1,201,258 | — | 30 Sep 2025 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
0.32%
|
241,891
|
$1,156,000 | — | 30 Sep 2025 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.31%
|
235,931
|
$1,132,469 | — | 30 Sep 2025 |
Institutional Holders of ACCENDRA HEALTH INC/VA/ - Common Stock (ACH) as of Q4 2025
As of 31 Dec 2025,
ACCENDRA HEALTH INC/VA/ - Common Stock (ACH) was held by
163 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
69,007,474 shares.
The largest 10 holders included
Coliseum Capital Management, LLC, VANGUARD GROUP INC, BlackRock, Inc., CHARLES SCHWAB INVESTMENT MANAGEMENT INC, D. E. Shaw & Co., Inc., Invenomic Capital Management LP, DIMENSIONAL FUND ADVISORS LP, MILLENNIUM MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC, and PARADIGM CAPITAL MANAGEMENT INC/NY.
This page lists
163
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2025 vs Q3 2025 Across Filers
Q3 2025 holders
199
Q4 2025 holders
163
Holder diff
-36
| Investor | Q3 2025 Shares | Q4 2025 Shares | Share Diff | Share Chg % | Q3 2025 Value $ | Q4 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.